Authors

• Hsiang Chou (ORCID: https://orcid.org/0000-0002-9849-0559)
• Christophe Gonçalves (ORCID: https://orcid.org/0000-0003-2660-1616)
• Natascha Gagnon (ORCID: https://orcid.org/0000-0002-4082-3787)
• Margarita Bartish (ORCID: https://orcid.org/0000-0002-8883-6165)
• Paige A. McCallum (ORCID: https://orcid.org/0009-0007-9027-3860)
• Meagan‐Helen Henderson Berg (ORCID: https://orcid.org/0000-0002-4622-2931)
• François Santinon
• Wilson H. Miller (ORCID: https://orcid.org/0000-0002-7408-1574)
• Madelyn Jean Abraham (ORCID: https://orcid.org/0009-0005-2884-6731)
• Khashayar Esfahani (ORCID: https://orcid.org/0000-0003-2221-3755)
• Sonia Victoria Del Rincon (ORCID: https://orcid.org/0000-0002-6350-0227)
• Θεόδωρος Παπαδόπουλος
• Vrinda Gupta
• Noah Wirasinghe

Institutions

• McGill University Health Centre (CA)
• Jewish General Hospital (CA)
• McGill University (CA)

Publication Details

Journal

Journal of Inflammation

Published

2025-11-06

DOI

https://doi.org/10.1186/s12950-025-00476-4

Primary Topic

PI3K/AKT/mTOR signaling in cancer

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Pfizer
• McGill University
• Cancer Research Society
• Vetenskapsrådet
• Merck Canada
• Canadian Institutes of Health Research